CTCBIO Inc (060590) — Financial Flexibility Index
CTCBIO Inc (060590) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of ₩5.85 Billion (operating CF ₩5.64 Billion minus capex ₩212.02 Million) represents 0% of total liabilities (₩77.43 Billion). Check CTCBIO Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CTCBIO Inc Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for CTCBIO Inc across 12 annual periods. See CTCBIO Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CTCBIO Inc (2013–2024)
Year-by-year free cash flow to debt coverage for CTCBIO Inc. For the full company profile including market capitalisation, see CTCBIO Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | ₩6.64 Billion | ₩4.50 Billion | ₩84.07 Billion | ▼ -29.3% |
| 2023 | 0.11x | ₩10.10 Billion | ₩8.22 Billion | ₩90.42 Billion | ▼ -52.0% |
| 2022 | 0.23x | ₩21.40 Billion | ₩18.22 Billion | ₩91.94 Billion | ▲ +138.2% |
| 2021 | 0.10x | ₩8.13 Billion | ₩6.46 Billion | ₩83.21 Billion | ▲ +304.9% |
| 2020 | 0.02x | ₩2.43 Billion | ₩510.09 Million | ₩100.86 Billion | ▼ -30.7% |
| 2019 | 0.03x | ₩3.89 Billion | ₩1.68 Billion | ₩111.76 Billion | ▲ +474.3% |
| 2018 | -0.01x | ₩-974.74 Million | ₩-2.47 Billion | ₩104.82 Billion | ▼ -126.1% |
| 2017 | 0.04x | ₩4.20 Billion | ₩295.30 Million | ₩117.82 Billion | ▼ -82.9% |
| 2016 | 0.21x | ₩20.33 Billion | ₩6.86 Billion | ₩97.78 Billion | ▼ -21.9% |
| 2015 | 0.27x | ₩25.15 Billion | ₩1.44 Billion | ₩94.47 Billion | ▼ -25.7% |
| 2014 | 0.36x | ₩27.47 Billion | ₩-347.74 Million | ₩76.63 Billion | ▲ +137.6% |
| 2013 | 0.15x | ₩8.79 Billion | ₩2.74 Billion | ₩58.25 Billion | — |